This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Arcalyst News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Arcalyst News

Sort by: relevance (24 hours) relevance date
  • Regeneron Reports Third Quarter 2009 Financial and Operating Results 3 Nov 2009 12:33 GMT
    ... 2009, lower costs related to manufacturing clinical drug supplies. Sanofi-aventis also incurs aflibercept development expenses ... 2009 and 2008, deferred revenue related to ARCALYST net product sales totaled $5.0 million and ... discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ...

  • Regeneron Reports Third Quarter 2009 Financial and Operating Results (PRN) 3 Nov 2009 12:33 GMT
    ... 2009, lower costs related to manufacturing clinical drug supplies. Sanofi-aventis also incurs aflibercept development expenses ... 2009 and 2008, deferred revenue related to ARCALYST net product sales totaled $5.0 million and ... discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ...

  • Novartis biological drug IlarisĀ® approved in EU to treat children and adults with CAPS, a rare debil 1 Nov 2009 16:14 GMT
    ... * First drug approved in EU for patients as young ... auto-inflammatory disease with debilitating symptoms and few treatment options[1],[2],[3]. The accelerated EU decision follows approvals ... 2009. [4.] Ilaris (canakinumab) prescribing information. [5.] Arcalyst (rilonacept) prescribing information. [6.] Kineret (anakinra) prescribing ...

  • BUYINS.NET: REGN, EGLE, VG, SSS, DSCO, SRDX Expected To Be Lower After Earnings Releases on Wednesday 2 Nov 2009 12:37 GMT
    ... develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United ... United States. The companyas commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the ... of gout flares in patients initiating urate-lowering drug therapy. The companyas products under clinical trials ...

  • REGN, EGLE, VG, SSS, DSCO, SRDX Expected To Be Lower After Earnings Releases on Wednesday 2 Nov 2009 13:56 GMT
    ... develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United ... United States. The companyas commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the ... of gout flares in patients initiating urate-lowering drug therapy. The companyas products under clinical trials ...

  • Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associate 30 Oct 2009 18:31 GMT
    ... for rilonacept, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) with severe ... CAPS symptoms to date in the U.S. ARCALYST is the only treatment for CAPS in ... was approved by the U.S. Food and Drug Administration in February 2008 and has been ...

  • BUYINS.NET: CTL, REGN, ROCK, LZB, ALX, WSC Expected To Be Higher Leading Up To Next Earnings Releases 30 Oct 2009 11:18 GMT
    ... develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United ... United States. The companyas commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the ... of gout flares in patients initiating urate-lowering drug therapy. The companyas products under clinical trials ...

  • CTL, REGN, ROCK, LZB, ALX, WSC Expected To Be Higher Leading Up To Next Earnings Releases 30 Oct 2009 12:59 GMT
    ... develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United ... United States. The companyas commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the ... of gout flares in patients initiating urate-lowering drug therapy. The companyas products under clinical trials ...


1 - 15 / 18      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ARCALYST NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.